Sources | Names Used |
---|---|
GDSC1000 | Tivozanib |
CTRPv2 | tivozanib |
PharmacoGx | tivozanib |
Database | Identifier |
---|---|
Smiles: | CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl |
Inchikey: | SPMVMDHWKHCIDT-UHFFFAOYSA-N |
Pubchem: | 9911830 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LILRA1 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-07 |
mRNA | MYO18B | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
mRNA | GOLGA8N | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
mRNA | RPS3A | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-07 |
mRNA | APOL4 | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-07 |
mRNA | TRAPPC11 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-07 |
mRNA | SP7 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-07 |
mRNA | STON2 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
mRNA | ADGRE2 | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-07 |
mRNA | M1AP | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-07 |